Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleToxicology

Dendritic spine injury induced by the 8-hydroxy metabolite of Efavirenz

Luis B Tovar-y-Romo, Namandje N Bumpus, Daniel Pomerantz, Lindsay B Avery, Ned Sacktor, Justin C McArthur and Norman J Haughey
Journal of Pharmacology and Experimental Therapeutics September 19, 2012, jpet.112.195701; DOI: https://doi.org/10.1124/jpet.112.195701
Luis B Tovar-y-Romo
1 The Johns Hopkins University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Namandje N Bumpus
2 The Johns Hopkins University School of Medicine, Dept of Medicine, Department of Pharamcology;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Pomerantz
3 The Johns Hopkins University School of Medicine, Department of Neurology;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lindsay B Avery
4 The Johns Hopkins University School of Medicine, Department of Pharmacology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ned Sacktor
3 The Johns Hopkins University School of Medicine, Department of Neurology;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justin C McArthur
3 The Johns Hopkins University School of Medicine, Department of Neurology;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norman J Haughey
3 The Johns Hopkins University School of Medicine, Department of Neurology;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Despite combination antiretroviral therapies (cART), a significant proportion of HIV-infected patients develop HIV-associated neurocognitive disorders (HAND). Ongoing viral replication in the CNS due to poor brain penetration of cART may contribute to HAND. However, it has also been proposed that toxic effects of long-term cART may contribute to HAND. A better understanding of the neurotoxic potential of cART is critically needed in light of the use of CNS penetrating cART to contend with virus reservoir in brain. The Efavirenz (EFV) metabolites 7-hydroxyefavirenz (7-OH-EFV) and 8-hydroxyefavirenz (8-OH-EFV) were synthesized, purified, and chemical structures confirmed by mass spectrometry and NMR. The effects of EFV, 7-OH-EFV and 8-OH-EFV on calcium, dendritic spine morphology, and survival were determined in primary neurons. EFV, 7-OH-EFV and 8-OH-EFV each induced neuronal damage in a dose dependent manner. However, 8-OH-EFV was at-least an order of magnitude more toxic than EFV or 7-OH-EFV, inducing considerable damage to dendritic spines at a 10 nM concentration. The 8-OH-EFV metabolite evoked calcium flux in neurons, which was primarily mediated by L-type voltage operated calcium channels. Blockade of L-type VOCCs protected dendritic spines from 8-OH-EFV-induced damage. Concentrations of EFV and 8-OH-EFV in the cerebral spinal fluid of HIV-infected subjects taking EFV were within the range that damaged neurons in culture. These findings demonstrate that the 8-OH metabolite of EFV is a potent neurotoxin and highlight the importance of directly determining the effects of antiretroviral drugs, and drug metabolites on neurons and other brain cells.

  • antiretrovirals
  • drug metabolism
  • extrahepatic drug metabolism
  • HIV
  • neurodegeneration
  • Received April 16, 2012.
  • Revision received September 7, 2012.
  • Accepted September 10, 2012.
  • The American Society for Pharmacology and Experimental Therapeutics
Next
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 376 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 376, Issue 3
1 Mar 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Dendritic spine injury induced by the 8-hydroxy metabolite of Efavirenz
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleToxicology

Dendritic spine injury induced by the 8-hydroxy metabolite of Efavirenz

Luis B Tovar-y-Romo, Namandje N Bumpus, Daniel Pomerantz, Lindsay B Avery, Ned Sacktor, Justin C McArthur and Norman J Haughey
Journal of Pharmacology and Experimental Therapeutics September 19, 2012, jpet.112.195701; DOI: https://doi.org/10.1124/jpet.112.195701

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleToxicology

Dendritic spine injury induced by the 8-hydroxy metabolite of Efavirenz

Luis B Tovar-y-Romo, Namandje N Bumpus, Daniel Pomerantz, Lindsay B Avery, Ned Sacktor, Justin C McArthur and Norman J Haughey
Journal of Pharmacology and Experimental Therapeutics September 19, 2012, jpet.112.195701; DOI: https://doi.org/10.1124/jpet.112.195701
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Tolerability profile of a GalNAc3-conjugated ASO in Monkeys
  • Preclinical Safety of Lung Instillation of Thyroid Hormone
  • Nefazodone Inhibits Anaerobic Glycolysis
Show more Toxicology

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics